Discover the groundbreaking AMPLITUDE trial results, showcasing niraparib's effectiveness in treating metastatic prostate cancer with minimal safety concerns.
Gerhardt Attard, MD, PhD, FRCP
Gerhardt Attard, MD, PhD, FRCP, is a professor of medical oncology in University College London in the UK.
Articles by Gerhardt Attard, MD, PhD, FRCP